Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (301-310 of 721) with videos related to

Pageof 73
Sort By:
Plos One|March 26, 2015
Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?Constantin Lapa, Thomas Linsenmann, Katharina Lückerath, et al.
The Lancet. Oncology|January 5, 2025
Advances and challenges in precision imagingHedvig Hricak, Marius E Mayerhoefer, Ken Herrmann, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2024
Determining the cut-off value for the Minimal Documentation System (MIDOS2) screening tool to initiate specialized palliative care based on patient's subjective need for palliative support and symptom burden in inpatients with advanced cancerAnna Heinzelmann, Mitra Tewes, Sandy Müller, et al.
Nuclear Medicine Communications|June 15, 2026
Diagnostic value of integrated 18F-fluorodeoxyglucose PET/MRI in initial staging and recurrence detection of Ewing sarcomaMarcel Alexander Drews, Aleksandar Milosevic, Sebastian Zensen, et al.
Seminars in Nuclear Medicine|March 9, 2022
A Role of PET/MR in Breast Cancer?Nils Martin Bruckmann, Janna Morawitz, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2023
Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapyMoon Kim, Robert Seifert, Jana Fragemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2014
Small-animal PET imaging of isolated perfused rat heartTomohiko Yamane, Min-Jae Park, Dominik Richter, et al.
European Journal of Radiology|June 18, 2026
Evaluation of standardized uptake value (SUV) and apparent diffusion coefficient (ADC) as prognostic imaging parameters for primary Ewing sarcoma in hybrid 18F-FDG-PET/MRIMarcel A Drews, Aleksandar Milosevic, Johannes Florian Schröder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2022
Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in MiceJasmin M Klose, Jasmin Wosniack, Janette Iking, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2011
A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphomaKen Herrmann, Andreas K Buck, Tibor Schuster, et al.
Pageof 73

Showing results (301-310 of 721) with videos related to

Sort By:
Pageof 73
Plos One|March 26, 2015
Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?Constantin Lapa, Thomas Linsenmann, Katharina Lückerath, et al.
The Lancet. Oncology|January 5, 2025
Advances and challenges in precision imagingHedvig Hricak, Marius E Mayerhoefer, Ken Herrmann, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2024
Determining the cut-off value for the Minimal Documentation System (MIDOS2) screening tool to initiate specialized palliative care based on patient's subjective need for palliative support and symptom burden in inpatients with advanced cancerAnna Heinzelmann, Mitra Tewes, Sandy Müller, et al.
Nuclear Medicine Communications|June 15, 2026
Diagnostic value of integrated 18F-fluorodeoxyglucose PET/MRI in initial staging and recurrence detection of Ewing sarcomaMarcel Alexander Drews, Aleksandar Milosevic, Sebastian Zensen, et al.
Seminars in Nuclear Medicine|March 9, 2022
A Role of PET/MR in Breast Cancer?Nils Martin Bruckmann, Janna Morawitz, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 1, 2023
Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapyMoon Kim, Robert Seifert, Jana Fragemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2014
Small-animal PET imaging of isolated perfused rat heartTomohiko Yamane, Min-Jae Park, Dominik Richter, et al.
European Journal of Radiology|June 18, 2026
Evaluation of standardized uptake value (SUV) and apparent diffusion coefficient (ADC) as prognostic imaging parameters for primary Ewing sarcoma in hybrid 18F-FDG-PET/MRIMarcel A Drews, Aleksandar Milosevic, Johannes Florian Schröder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2022
Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in MiceJasmin M Klose, Jasmin Wosniack, Janette Iking, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2011
A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphomaKen Herrmann, Andreas K Buck, Tibor Schuster, et al.
Pageof 73